ArticleOncoimmunology2021

Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment.

Hélène Bonnevaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.